Search research articles
Contact Us
Filters
Showing results (171-180 of 328) with videos related to
Page
of 33
Sort By:
American Journal of Hematology
|
June 8, 2012
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
Stephen M Ansell, Matthew J Maurer, Steven C Ziesmer, et al.
Blood Cancer Journal
|
February 4, 2017
Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia
J G Sfeir, M T Drake, B R LaPlant, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Follicular Lymphoma
Kami Maddocks, Paul M Barr, Bruce D Cheson, et al.
Leukemia & Lymphoma
|
April 20, 2013
FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status
Hervé Ghesquières, Ahmet Dogan, Brian K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo, Michelle Byrtek, Keith L Dawson, et al.
Leukemia & Lymphoma
|
August 5, 2011
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
Clive S Zent, Brian J Smith, Zuhair K Ballas, et al.
JCO Oncology Practice
|
December 6, 2024
Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda
Bryan Valcarcel, Kerry J Savage, Brian K Link, et al.
Blood
|
June 16, 2011
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
Ivana N M Micallef, Matthew J Maurer, Gregory A Wiseman, et al.
Blood
|
July 28, 2019
Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma
Yucai Wang, Brian K Link, Thomas E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Follicular lymphoma in the United States: first report of the national LymphoCare study
Jonathan W Friedberg, Michael D Taylor, James R Cerhan, et al.
Page
of 33
Search research articles
Search
Showing results (171-180 of 328) with videos related to
Sort By:
Page
of 33
American Journal of Hematology
|
June 8, 2012
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
Stephen M Ansell, Matthew J Maurer, Steven C Ziesmer, et al.
Blood Cancer Journal
|
February 4, 2017
Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia
J G Sfeir, M T Drake, B R LaPlant, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Follicular Lymphoma
Kami Maddocks, Paul M Barr, Bruce D Cheson, et al.
Leukemia & Lymphoma
|
April 20, 2013
FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status
Hervé Ghesquières, Ahmet Dogan, Brian K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo, Michelle Byrtek, Keith L Dawson, et al.
Leukemia & Lymphoma
|
August 5, 2011
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
Clive S Zent, Brian J Smith, Zuhair K Ballas, et al.
JCO Oncology Practice
|
December 6, 2024
Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda
Bryan Valcarcel, Kerry J Savage, Brian K Link, et al.
Blood
|
June 16, 2011
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
Ivana N M Micallef, Matthew J Maurer, Gregory A Wiseman, et al.
Blood
|
July 28, 2019
Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma
Yucai Wang, Brian K Link, Thomas E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Follicular lymphoma in the United States: first report of the national LymphoCare study
Jonathan W Friedberg, Michael D Taylor, James R Cerhan, et al.
Page
of 33